65 year-old female with Alzheimer’s disease

Slides:



Advertisements
Similar presentations
Alzheimer’s Disease Savidra Lucatero, Vinita Mehrotra, Sabrina Rawlings, Jackie Wheeler, & Matt Zustiak.
Advertisements

Disorders with Complex Genetics Alzheimer’s Disease.
Alzheimer’s Disease Stephen S. Flitman, MD Medical Director 21 st Century Neurology a division of Xenoscience, Inc. Phoenix, Arizona.
Alzheimer’s Disease Edwin Onattu P. 3.
Etiopathogenesis of Alzheimer's disease
Results All neuropathologies were associated with clinical dementia when controlling for cortical plaques and tangles except Hirano bodies, GVD and brainstem.
Disorders with Complex Genetics DCGs. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
ALZHEIMER'S DISEASE (AD)
MECHANISMS OF AGING TheoryPrinciples DNA & Genetic Theory Aging is predetermined by genetic programming. Neuroendocrine Theory Loss of hypothalamic regulation.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Disorders with Complex Genetics. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to converse,
Aging-Related Memory Disorders Alzheimer’s Disease From Mechanisms of Memory by J. David Sweatt, Ph.D.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
Alzheimer’s Disease BRAIN, THE FINAL FRONTIER BRAIN, THE FINAL FRONTIER Kiminobu Sugaya, Ph.D.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
?v=pQO3Tq3KQL4 ohlTE.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Alzheimer’s Research UK is the UK’s leading charity specialising in finding preventions, treatments and a cure for dementia.
Alzheimer’s Disease By Evelyn B. Kelly 2-7 Healthy Brain Advanced Alzheimer ’ s.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
Alzheimer’s Disease (AD)
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Absence of β-Amyloid Deposits After Immunization in.
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
Alzheimer Disease (Senile Dementia) Characterized by progressive memory loss, is increasingly common in developed countries as populations include more.
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
Alzheimer’s Disease and Cholesterol
Copyright © 1999 American Medical Association. All rights reserved.
Fig. 1 The effects of modelling global volume for the analysis of PDD relative to controls. Atrophy in PDD shown (A) compensated for differences in head.
Title: Alzheimer’s disease and the social
Aging in the CNS.
Copyright © 2004 American Medical Association. All rights reserved.
Alzheimer’s Disease Putting the pieces together
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Small section of the neocortex from a patient with Alzheimer disease showing two classical neuropathologic lesions of the disease. A. The modified silver.
Alzheimer’s Disease.
Alzheimer Disease Mayo Clinic Proceedings
Amnesia Syndromes Lecture 21.
Q: How can we prevent or treat Alzheimer’s Disease?
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Progress Report on Alzheimer’s Disease
Disorders with Complex Genetics
65 year-old female who collapsed at home
Chapter 4 Aging, Dementia, and Alzheimer Disease
Aβ amyloid cortical and hippocampal pathology in McGill Thy1-APP transgenic (Tg) mice. A1: Absence of Aβ in non-transgenic (Non-Tg) littermate (ccx = cortex;
Pathways to Primary Neurodegenerative Disease
Volume 15, Issue 13, Pages (December 2016)
Neurological Disorders
Tara L. Spires-Jones, Bradley T. Hyman  Neuron 
Neuroplasticity Failure in Alzheimer's Disease
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Introduction to degenerative brain disease
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease  W. Robert Bell, Yang An,
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Presentation transcript:

65 year-old female with Alzheimer’s disease Lananh Nguyen, M.D. Division of Neuropathology University of Pittsburgh Medical Center

An autopsy was performed. Identify the structures arrow.

Lateral geniculate nucleus An autopsy was performed. Identify the structures arrow. Corpus callosum Caudate, tail Thalamus Lateral geniculate nucleus Hippocampus

Note the atrophy in the brain with the Alzheimer’s disease. Normal Severe atrophy library.med.utah.edu

What microscopic pathology is in abundance in Alzheimer’s disease (AD)?

What microscopic pathology is in abundance in Alzheimer’s disease (AD)? Neuritic plaques Neurofibrillary tangles Amyloid plaques

What stains would you use to evaluate microscopic pathology in Alzheimer’s disease (AD) for these features? Neuritic plaques Neurofibrillary tangles Amyloid plaques

What stains would you use to evaluate microscopic pathology in Alzheimer’s disease (AD) for these features? Neuritic plaques : Bielchowsky stain Neurofibrillary tangles: Phosphorylated tau stain Amyloid plaques: Beta amyloid stain

What “body” would you expect to see in the hippocampus of a person with AD Hirano bodies

Where in the hippocampus can you find these bodies?

Where in the hippocampus can you find these bodies? CA1 region of the hippocampus CA3 CA2 CA4 CA1 Dentate gyrus

What are the 4 most common genes linked to AD? Amyloid precursor protein mutation (causative gene) Presenilin 1 and Presenilin 2 mutations (causative gene) Apolipoprotein E4 (risk gene)